DiaCarta SARS-CoV-2 Test Receives FDA EUA
DiaCarta recently expanded manufacturing capacity to 500,000 tests per week to meet the increasing demand for PCR tests to monitor covid-19.
Read MorePosted by | May 1, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
DiaCarta recently expanded manufacturing capacity to 500,000 tests per week to meet the increasing demand for PCR tests to monitor covid-19.
Read MorePosted by | Apr 30, 2020 | Cleaners & Disinfectants, Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Two new ultraviolet C light devices are designed to autonomously and continuously treat the air and surfaces for harmful bacteria, fungi, and viruses.
Read MorePosted by | Apr 29, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases, Research |
“Bright’s abrupt reassignment raises serious questions whether the Trump administration retaliated against him for advocating for science.”
Read MorePosted by | Apr 27, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The covid-19 assay has been validated by ChromaCode, and an independent review of the validation data by FDA is pending.
Read MorePosted by | Apr 27, 2020 | Emerging & Zoonotic Diseases, Infectious Diseases |
The project aims to facilitate early diagnosis and support efforts to stop the Ebola virus disease epidemic.
Read More